Regulatory Strategy
Global regulatory pathway selection, development strategy and market-entry sequencing.
Services
Complex Science. Clear Regulatory Strategy.
Every engagement produces a defined deliverable: a decision you can act on, a document you can submit, or a remediation plan you can resource.
Regulatory Dossier Development
CTD/eCTD authoring, review and compilation across Modules 1–5.
Regulatory Submissions
Submission planning, publishing, filing and validation support.
Regulatory Gap Assessment
Assessment of existing dossiers against target-market requirements and known deficiency patterns.
CMC Regulatory Affairs
Pharmaceutical development, manufacturing, control strategy and quality documentation.
Medical & Scientific Writing
Clinical, nonclinical and summary documentation written for assessor review.
Regulatory Intelligence
Guideline tracking, precedent analysis and requirement mapping across target markets.
Agency Interaction
Meeting preparation, briefing packages and deficiency response strategy.
Product Registration
Country-specific registration dossiers, legalisation and local requirements.
Lifecycle Management
Variations, renewals, supplements, commitments and post-approval changes.
Regulatory Due Diligence
Product, dossier, manufacturing and compliance assessment for licensing decisions.
Labeling & Artwork
SmPC, PIL, cartons, artwork control and global labeling strategy.
Pharmaceutical
Pharmaceutical Regulatory Affairs
Procedure selection, dossier construction and defence of the data package — for generics, hybrids, innovator products and biologics.
Generic medicinesInnovator productsNew chemical entities505(b)(2)ANDANDABLAMAANational proceduresDecentralised proceduresMutual recognitionHybrid applicationsLine extensionsVariationsRenewalsDMFASMFCEPCMC regulatory strategy
FAQs
Questions Clients Ask Before Engaging
When should regulatory strategy begin?
Before the development plan is locked. Pathway choice determines the comparator, the study design, the specification strategy and the dossier format — all of which are expensive to change later.
What is the difference between CTD and eCTD?
CTD is the content structure agreed under ICH. eCTD is the electronic format and lifecycle mechanism used to submit and maintain that content, with sequence tracking and lifecycle operators.
Can an existing dossier be adapted for another market?
Frequently, yes — but rarely by reformatting alone. Differences usually appear in Module 1, comparator selection, stability zone data, local testing and labeling.
What is a regulatory gap assessment?
A structured review of an existing dossier against a target market's current requirements and known deficiency patterns, producing a prioritised remediation plan.
Do you support health authority questions?
Yes. We assess the question behind the question, define the response strategy, and prepare scientifically defensible responses within the clock.
How do engagements typically start?
With a scoped assessment: product, current data, target markets and objective. That output is usable whether or not you continue with us.